COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Periventricular Calcification, Abnormal Pterins and Dry Thickened Skin: Expanding the Clinical Spectrum of RMND1?
|
26238252 |
2016 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
RMND1 deficiency associated with neonatal lactic acidosis, infantile onset renal failure, deafness, and multiorgan involvement.
|
25604853 |
2015 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies.
|
25058219 |
2014 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Infantile encephaloneuromyopathy and defective mitochondrial translation are due to a homozygous RMND1 mutation.
|
23022099 |
2012 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Infantile encephaloneuromyopathy and defective mitochondrial translation are due to a homozygous RMND1 mutation.
|
23022099 |
2012 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
An RMND1 Mutation causes encephalopathy associated with multiple oxidative phosphorylation complex deficiencies and a mitochondrial translation defect.
|
23022098 |
2012 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Infantile encephaloneuromyopathy and defective mitochondrial translation are due to a homozygous RMND1 mutation.
|
23022099 |
2012 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
An RMND1 Mutation causes encephalopathy associated with multiple oxidative phosphorylation complex deficiencies and a mitochondrial translation defect.
|
23022098 |
2012 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Malignant neoplasm of breast
|
0.310 |
Biomarker
|
disease |
CTD_human |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
|
29915430 |
2018 |
Breast Carcinoma
|
0.310 |
Biomarker
|
disease |
CTD_human |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
|
29915430 |
2018 |
Malignant neoplasm of breast
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
We examined the association of rs2046210 and its six linkage disequilibrium SNPs with clinicopathological characteristics, prognosis, and gene expression levels of ESR1 and the C6ORFs (C6ORF97:CCDC170, C6ORF211, C6ORF96:RMND1) in 344 breast cancer tissue samples and 253 corresponding samples of adjacent normal tissue.
|
25370037 |
2015 |
Breast Carcinoma
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
We examined the association of rs2046210 and its six linkage disequilibrium SNPs with clinicopathological characteristics, prognosis, and gene expression levels of ESR1 and the C6ORFs (C6ORF97:CCDC170, C6ORF211, C6ORF96:RMND1) in 344 breast cancer tissue samples and 253 corresponding samples of adjacent normal tissue.
|
25370037 |
2015 |
Mammary Neoplasms, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
|
29915430 |
2018 |
Mammary Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
|
29915430 |
2018 |
Mammary Carcinoma, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
|
29915430 |
2018 |
Acidosis, Lactic
|
0.120 |
GeneticVariation
|
phenotype |
BEFREE |
Careful clinical phenotyping, including for lactic acidosis, deafness, and severe muscle involvement seen in RMND1 mutation positive individuals, and MRI pattern recognition will be important in differentiating these patients from children with congenital infections like cytomegalovirus.
|
27843092 |
2017 |
Acidosis, Lactic
|
0.120 |
Biomarker
|
phenotype |
BEFREE |
RMND1 deficiency associated with neonatal lactic acidosis, infantile onset renal failure, deafness, and multiorgan involvement.
|
25604853 |
2015 |
Acidosis, Lactic
|
0.120 |
Biomarker
|
phenotype |
HPO |
|
|
|
Mitochondrial Diseases
|
0.110 |
Biomarker
|
group |
BEFREE |
Characterization of the renal phenotype in RMND1-related mitochondrial disease.
|
31568715 |
2019 |
Seizures
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
Recently, two research groups reported that mutations in RMND1 were associated with encephalopathy, elevated lactate, hypotonia, and in some patients seizures or myoclonia in individuals from two consanguineous families.
|
26395190 |
2016 |
Mitochondrial Diseases
|
0.110 |
CausalMutation
|
group |
CLINVAR |
The clinical, biochemical and genetic features associated with RMND1-related mitochondrial disease.
|
27412952 |
2016 |
hearing impairment
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
Hearing impairment and renal failure associated with RMND1 mutations.
|
26395190 |
2016 |